Business1 hOctober 1, 2026, 09:00

OpenEvidence raises $250M at $15B valuation

OpenEvidence, the maker of an AI-driven clinical decision support tool, confirmed it has raised an additional $250 million. The company is now valued at $15 billion.

Forbes

Open source

OpenEvidence raised an additional $250 million
The company is valued at $15 billion
Its product is an AI clinical decision support tool

#OpenEvidence

More stories in swipe mode🔥 Trending now: Hackers stole data on 2.8M US military personnel: Social Security numbers, names, birth dates.

Flow raises $50M Series B at $750M valuation

Business

Instinct raises $1B at $10B valuation for personal AI agents

Business

EliseAI raises $350M at $4B valuation

Business

OpenEvidence raises $250M at $15B valuation

Flow raises $50M Series B at $750M valuation

Instinct raises $1B at $10B valuation for personal AI agents

EliseAI raises $350M at $4B valuation

Mistral AI raises €3B led by Samsung at €21B valuation